Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0345904 (
liver cancer
)
15,188
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Liver cancer
is one of the deadliest cancers in the world. To find effective therapies for this cancer, it is indispensable to identify key genes, which may play critical roles in the incidence of the
liver cancer
. To identify key genes of the
liver cancer
with high accuracy, we integrated multiple microarray gene expression data sets to compute common differentially expressed genes, which will result more accurate than those from individual data set. To find the main functions or pathways that these genes are involved in, some enrichment analyses were performed including functional enrichment analysis, pathway enrichment analysis, and disease association study. Based on these genes, a protein-protein interaction network was constructed and analyzed to identify key genes of the
liver cancer
by combining the local and global influence of nodes in the network. The identified key genes, such as TOP2A, ESR1, and
KMO
, have been demonstrated to be key biomarkers of the
liver cancer
in many publications. All the results suggest that our method can effectively identify key genes of the
liver cancer
. Moreover, our method can be applied to other types of data sets to select key genes of other complex diseases.
...
PMID:Identifying Key Genes of Liver Cancer by Networking of Multiple Data Sets. 3029 39